Go to the profile of NIAID Technology Transfer and Intellectual Property Office

NIAID Technology Transfer and Intellectual Property Office

 

About NIAID Technology Transfer and Intellectual Property Office

NIAID’s technology transfer office, TTIPO, is a one-stop resource for organizations interested in partnering with NIAID to access, develop, and manage the translation of research discoveries into medically beneficial products. TTIPO seeks to expand NIAID’s innovation pipeline with existing and new partners in areas such as newly emerging and re-emerging infectious diseases (e.g., dengue, Zika, Ebola, influenza, methicillin-resistant Staphylococcus aureus and HIV/AIDS), biodefense (e.g., smallpox and anthrax), and immune-mediated diseases (e.g., asthma and allergy).

Therapeutic Areas

Autoimmune disorders Infectious Inflammation

Technologies

Antimicrobial Biologics Diagnostics Nucleic acids Peptides Small molecules Vaccines

Company Type

Public/Non-profit organisation

State of Ownership

Public

Influencer Of

Popular Contributions

Topics

Topics contributed to:

Academic/Non-profit organisation

Editions participated in:

June 2016